OncLive TV

OncLive® TV is an editorial video program featuring one-on-one live and/or virtual interviews with key opinion leaders in the oncology field for their expert insight on breaking news, regulatory updates, practice-changing data presented at medical meetings, and other pivotal topics in a cancer specialty, including breast cancer, lung cancer, genitourinary cancers, gastrointestinal cancers, gynecologic cancers, and hematologic cancers.

Dr. Vaishampayan on the Expanding Role of TKI/Immunotherapy Combinations in mRCC

November 6th 2020

Ulka N. Vaishampayan, MBBS, FAB, discusses the expanding role of TKI/immunotherapy combinations in metastatic renal cell carcinoma.

Dr. Rini on Choosing Between IO/IO or IO/TKI Combinations in mRCC

November 6th 2020

Brian I. Rini, MD, discusses choosing between combinations of dual immunotherapy and immunotherapy/VEGF TKIs in metastatic renal cell carcinoma.

Dr. Markman on the Benefit of PARP Inhibitors in Ovarian Cancer

November 6th 2020

Maurie Markman, MD, discusses the utility of PARP inhibitors in ovarian cancer.

Dr. Yu on the Role of Radiation in Prostate Cancer

November 6th 2020

James B. Yu, MD, MHS, discusses the utility of radiation in men with prostate cancer.

Dr. Braunschweig on Mitigating the Toxicities of CAR T-Cell Therapy in Lymphoma

November 5th 2020

Ira Braunschweig, MD, discusses mitigating the toxicities that are associated with CAR T-cell therapy in lymphoma.

Dr. Sun on the Use of Ramucirumab/Paclitaxel in Metastatic Gastric Cancer

November 5th 2020

Weijing Sun, MD, FACP, discusses the use of ramucirumab plus paclitaxel in metastatic gastric cancer.

Dr. Cavnar on the Management of Liver Metastases in CRC

November 5th 2020

Michael J. Cavnar, MD, discusses the management of patients with liver metastases in colorectal cancer.

Dr. Abraham on Surgical Improvements in TGCT

November 5th 2020

John A. Abraham, MD, FACS, discusses surgical improvements in tenosynovial giant cell tumor.

Dr. Mahal on the Emerging Role of Epigenomics in Prostate Cancer

November 5th 2020

Brandon Mahal, MD, discusses the emerging role of epigenomics in prostate cancer.

Dr. Popat on Unmet Needs in Triple-Class Refractory Multiple Myeloma

November 5th 2020

Rakesh Popat, BSc, MBBS, MRCP, FRCPath, PhD, discusses unmet needs in triple-class refractory multiple myeloma.

Dr. Weber on the Evolution of Melanoma Treatment

November 5th 2020

Jeffrey S. Weber, MD, PhD, discusses the evolution of the treatment paradigm in melanoma.

Dr. Jhaveri on Outlining First-Line Treatment in HER2+ Breast Cancer

November 5th 2020

Komal Jhaveri, MD, FACP, discusses the importance of outlining the first-line treatment course for patients with HER2-positive breast cancer.

Dr. Awan on the Importance of Collaborative Care in CLL

November 4th 2020

Farrukh Awan, MD, discusses the importance of collaborative care in chronic lymphocytic leukemia.

Dr. Baskin on Racial Disparities and Early Screening in Prostate Cancer

November 4th 2020

Monica L. Baskin, PhD, discusses the roles of race and early screening in prostate cancer.

Dr. Hill on the Approval of Brexucabtagene Autoleucel in MCL

November 4th 2020

Brian T. Hill, MD, PhD, discusses the approval of brexucabtagene autoleucel in mantle cell lymphoma.

Dr. Braunschweig on Selecting Between Transplant and CAR T-Cell Therapy in DLBCL

November 4th 2020

Ira Braunschweig, MD, discusses factors to consider when selecting between autologous stem cell transplant, allogeneic stem cell transplant, and CAR T-cell therapy in diffuse large B-cell lymphoma.

Dr. Srinivasan on the Challenges of Developing New Therapies in Rare RCC Subtypes

November 4th 2020

Ramaprasad Srinivasan, MD, PhD, discusses the challenges of developing new therapies to treat patients with rare renal cell carcinoma subtypes.

Dr. Luke on the Role of Targeted Therapy in Melanoma

November 4th 2020

Jason J. Luke, MD, FACP, discusses the role of targeted therapy in melanoma.

Dr. Mascarenhas on the Promise of Imetelstat in Myelofibrosis

November 4th 2020

John O. Mascarenhas, MD, discusses the promise of imetelstat in myelofibrosis.

Dr. Pemmaraju on a New Era of Treatment Strategies in BPDCN

November 4th 2020

Naveen Pemmaraju, MD, discusses current treatment strategies in blastic plasmacytoid dendritic cell neoplasm.